Opus Capital Group, LLC Anavex Life Sciences Corp. Transaction History
Opus Capital Group, LLC
- $701 Million
- Q2 2024
A detailed history of Opus Capital Group, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Opus Capital Group, LLC holds 32,700 shares of AVXL stock, worth $183,120. This represents 0.02% of its overall portfolio holdings.
Number of Shares
32,700
Previous 30,500
7.21%
Holding current value
$183,120
Previous $155,000
10.97%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding AVXL
# of Institutions
152Shares Held
26.5MCall Options Held
674KPut Options Held
811K-
Black Rock Inc. New York, NY6.39MShares$35.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.55MShares$25.5 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.83MShares$10.3 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.01MShares$5.67 Million0.01% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $436M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...